Boule Diagnostics AB (publ) logo

Boule Diagnostics AB (publ) (BOUL)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
3. 60
0
0%
kr
344.84M Market Cap
- P/E Ratio
2.2% Div Yield
10,063 Volume
- Eps
kr 3.6
Previous Close
Add Transaction
Day Range
3.6 3.65
Year Range
3.14 10.6
Want to track BOUL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BOUL closed today higher at kr3.6, an increase of 0% from yesterday's close, completing a monthly increase of 3.4483% or kr0.12. Over the past 12 months, BOUL stock lost -30.2326%.
BOUL is not paying dividends to its shareholders.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
Boule Diagnostics AB (publ) has completed 1 stock splits, with the recent split occurring on Jun 01, 2018.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

BOUL Chart

People also search for

Pricer AB
kr -
-
BioArctic AB
kr -
-
DIAMYD MEDICAL AB
kr -
-
Bactiguard Holding AB
kr -
-
Genovis AB
kr 19.7
-0.5051%

Boule Diagnostics AB (publ) (BOUL) FAQ

What is the stock price today?

The current price is kr3.60.

On which exchange is it traded?

Boule Diagnostics AB (publ) is listed on XSTO.

What is its stock symbol?

The ticker symbol is BOUL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, the market cap is 344.84M.

Has Boule Diagnostics AB (publ) ever had a stock split?

Boule Diagnostics AB (publ) had 1 splits and the recent split was on Jun 01, 2018.

Boule Diagnostics AB (publ) Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Torben Nielsen CEO
XSTO Exchange
SE0011231158 ISIN
Sweden Country
200 Employees
6 May 2022 Last Dividend
1 Jun 2018 Last Split
- IPO Date

Overview

Boule Diagnostics AB (publ) is a key player in the global blood diagnostics market, offering a comprehensive suite of products aimed at enhancing medical diagnostics. Founded in 1956, the company has established a robust presence across various continents, including the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. Headquartered in Spånga, Sweden, Boule Diagnostics focuses on developing, manufacturing, and marketing precision instruments and consumable products for blood analysis. Catering primarily to small and medium-sized hospitals, clinics, laboratories, veterinary clinics, and diagnostics companies, the firm stands out for its dedication to advancing hematology diagnostics through innovation and quality.

Products and Services

  • Hematology Analyzers: Boule Diagnostics offers advanced hematology analyzers under the Swelab, Medonic, and Quintus brands. These analyzers are designed for comprehensive and accurate blood assessment, catering to the needs of healthcare institutions by providing critical data for diagnosing and monitoring various medical conditions.
  • Reagents, Controls, and Calibrators: To complement their hematology analyzers, Boule Diagnostics provides a full range of reagents, controls, and calibrators. These consumables are essential for ensuring the precision and reliability of test results, adhering to stringent quality standards required in clinical diagnostics.
  • Veterinary Hematology and Clinical Chemistry Analyzer Systems: Recognizing the importance of veterinary diagnostics, Boule Diagnostics has developed the Exigo brand, offering specialized hematology and clinical chemistry analyzer systems for veterinary use. These products come equipped with tailored reagents and panels, ensuring accurate diagnostics for a wide range of animal species.

Contact Information

Address: Domnarvsgatan 4
Phone: 46 87 44 77 00